Group 1: R&D Investment and Innovation Capacity - Jiangsu's R&D investment intensity has steadily increased from 2.95% in 2021 to 3.36% in 2023, positioning it at a mid-to-high level among innovative countries and regions [1] - Jiangsu's regional innovation capability ranked second nationally last year and maintained this position this year, with a narrowing gap to the top [1] - The province has launched over 9,000 basic research projects during the "14th Five-Year Plan" period, emphasizing the importance of original innovation [2] Group 2: Major Technological Platforms and Achievements - Jiangsu has established 44 national key laboratories and is developing the Suzhou Laboratory, which focuses on materials research [3] - The province has made significant breakthroughs, including the first observation of a graviton mode in condensed matter and the establishment of the world's first 8-inch silicon-based gallium nitride production line [3] - Jiangsu's innovation in pharmaceuticals is notable, with seven innovative drugs approved during the "14th Five-Year Plan," compared to just one during the previous period [5] Group 3: Support for Enterprises and Startups - The number of listed companies on the Science and Technology Innovation Board in Jiangsu has increased from 42 at the end of the "13th Five-Year Plan" to 114, the highest in the country [5] - Jiangsu has implemented policies to support high-tech enterprises and unicorn companies, resulting in a growth of technology-based SMEs from 40,000 to 89,000 [6] - The province is fostering innovation through high-tech zones and collaborations with universities, enhancing the local innovation ecosystem [7] Group 4: Innovation Ecosystem and Financial Support - Jiangsu is reforming its technology system to eliminate barriers to innovation, including pilot reforms in technology achievement ownership [8] - The province has established a comprehensive financial support system for technology startups, with over 640 billion yuan in new loans for the technology sector in the past two years [9] - The Jiangsu Provincial Technology Finance Integration Conference has been held for three consecutive years, promoting the integration of technology and finance [9]

Group 1: Company Performance - In the first half of 2025, the company achieved operating revenue of 239 million yuan, a year-on-year increase of 29.03% [1] - The net profit attributable to shareholders was 33.37 million yuan, up 11.48% year-on-year, while the net profit after deducting non-recurring gains and losses was 31.52 million yuan, reflecting a 19.00% increase [1] - The company plans to distribute a cash dividend of 0.50 yuan per 10 shares, totaling 20.17 million yuan, which accounts for 60.43% of the net profit attributable to shareholders for the first half of 2025 [1] Group 2: Industry Context - The company primarily engages in third-party testing and analysis services for the semiconductor industry, providing failure analysis, material analysis, and reliability analysis [2] - The demand for semiconductor testing and analysis has been growing due to the rapid development of the global semiconductor industry and the increasing complexity of manufacturing processes [2] - The trend towards specialization in the semiconductor industry has led to the emergence of independent testing and analysis as a significant segment, benefiting the third-party testing and analysis sector [2] Group 3: Market Position - The company ranks among the top players in the domestic semiconductor third-party testing and analysis market, with a main business revenue of 415 million yuan in 2024, of which 364 million yuan comes from domestic sales [2] - In the failure analysis and material analysis market, the company is estimated to achieve domestic revenue of 353 million yuan in 2024, capturing approximately 7.44% of the market share [3] - The company has established a strong competitive position in the market, recognized for its diverse testing projects and precise diagnostic capabilities, making it one of the most influential third-party semiconductor testing and analysis laboratories in China [3]

Core Viewpoint - The report highlights the financial performance and operational strategies of Wintech Nano (Suzhou) Co., Ltd., emphasizing its growth in the semiconductor third-party testing and analysis market, driven by increasing demand for advanced semiconductor technologies and services [1][3][14]. Financial Performance - The company achieved a revenue of RMB 239.24 million in the first half of 2025, representing a year-on-year increase of 29.03% compared to RMB 185.42 million in the same period of 2024 [3][14]. - The net profit attributable to shareholders was RMB 33.37 million, up 11.48% from RMB 29.93 million in the previous year [3][14]. - The total assets reached RMB 1.68 billion, a 12.67% increase from RMB 1.49 billion at the end of the previous year [3][14]. Business Overview - The company specializes in semiconductor third-party testing and analysis services, providing failure analysis, material analysis, and reliability analysis to clients across the semiconductor industry [5][14]. - Wintech Nano has established itself as a leading player in the domestic market, particularly in high-difficulty areas such as failure analysis and material analysis, with a significant market share [5][14]. - The company has adopted a "Labless" operational model, which allows semiconductor firms to outsource testing and analysis, reducing costs and improving efficiency [12][13]. Market Trends - The global semiconductor market reached USD 346 billion in the first half of 2025, reflecting an 18.9% year-on-year growth, driven by strong demand in logic chips, memory chips, and sensors [5][10]. - The domestic market for semiconductor third-party testing and analysis is expected to expand significantly, with estimates suggesting a market size of approximately RMB 4.747 billion in 2024 for failure and material analysis [5][10]. - The increasing complexity of semiconductor products and the rise of applications such as AI, 5G, and IoT are expected to drive further demand for testing and analysis services [9][10]. Operational Strategies - The company has implemented a multi-site laboratory strategy, with facilities in Suzhou, Nanjing, Fujian, Shenzhen, Qingdao, and Beijing, enhancing its service capabilities across key markets [11][14]. - Wintech Nano focuses on continuous R&D investment, developing core technologies in failure analysis, material analysis, and reliability analysis, which are crucial for meeting the evolving needs of the semiconductor industry [10][14]. - The company has established a strong marketing team and utilizes direct sales strategies to engage with clients, ensuring a comprehensive understanding of customer needs and timely service delivery [7][14].

Group 1: Fund Overview - Chunhou Lijia Mixed A Fund, established on July 29, 2022, has a total management scale of 0.02 billion yuan [1] - The fund aims to create stable returns exceeding the performance benchmark through asset allocation while strictly controlling risks and maintaining liquidity [1] - As of April 25, 2025, the fund achieved a one-year return of 10.25%, outperforming the benchmark growth rate of 4.93% and the CSI Mixed Fund Index return of 6.33% [1] Group 2: Shareholder Structure - The proportion of institutional investors in the fund reached 9.64%, increasing by 9.64 percentage points over six months [1] - Fund employees hold 85.21% of the shares, totaling 855,500 shares [1] Group 3: Industry Insights - The semiconductor industry is experiencing rapid growth, driving a surge in demand for semiconductor testing and analysis [2] - The third-party laboratory testing and analysis market in the semiconductor sector has significant growth potential, with the Labless model gaining industry recognition [2] - Continuous R&D investments, driven by advancements in semiconductor technology, are expected to sustain the growth of third-party testing and analysis demand, particularly in advanced processes [2] Group 4: Company Service and Sales Model - The company employs a production model based on sales, implementing order-based production tailored to customer needs [2] - It focuses on quality and efficiency in testing services, continuously optimizing production processes to enhance service quality [2] - The sales model is direct, allowing the company to provide personalized testing solutions and respond promptly to customer needs [2] Group 5: Competitive Advantages - The company has a technological R&D advantage, with capabilities covering advanced processes up to 3nm, positioning it among industry leaders [2] - It holds a strong market position in the third-party testing and analysis market, with significant revenue scale and market share [2] - The company is recognized as a national-level "little giant" and has established a strong brand effect within the industry [2] - The technical team comprises individuals with experience from top institutions and global semiconductor firms, enhancing the company's technical strength [2] - The company has a unique international advantage with laboratories in both China and Singapore, differentiating it from domestic competitors [2] Group 6: Future Development Plans - The company plans to leverage its technical talent and maintain high R&D investment to capitalize on domestic semiconductor development opportunities [2] - It aims to enhance its analytical capabilities in advanced processes, packaging, high-performance chips, and third-generation semiconductor materials [2] - The company will expand its focus on failure analysis and reliability analysis for automotive-grade chips while exploring new fields like aerospace and biomedicine [2] - It intends to broaden its customer reach through a multi-point domestic layout and standardize laboratory replication to accelerate business expansion [2]

胜科纳米IPO：20年挖掘"护城河"收获营利双高 产销研三线同步布局保障未 来成长 3月25日，胜科纳米（苏州）股份有限公司（简称"胜科纳米"）正式在科创板上市。 据悉，胜科纳米成立于2012年，其技术根源可以追溯至公司创始人于2004年创办运营的半导体第三方检测分析实验室。二十多年间，公司创始团队始终 聚焦失效分析及材料分析等专业化与高附加值方向，长期技术积累带来业绩兑现，近年公司营收与归母净利润高速增长。 2020年到2024年，胜科纳米营收复合增速超30%，归母净利润复合增速超40%。 此次科创板IPO发行股票数量4033.1149万股，发行价格为9.08元/股，预计募资总额3.66亿元，超过IPO申请时拟募资额2.97亿元，募集资金主要用于投 资"苏州检测分析能力提升建设项目"。 其中，失效分析（FA）业务是公司营收的主要贡献者，2021年到2024年上半年（下称"报告期内"）该业务营收占总营收的比重分别为71.35%、 61.98%、56.47%、66.10%。而近年公司材料分析（MA）业务成长迅速，同期营收比重分别为27.09%、34.27%、40.43%、30.99%，近年营收占比超过三 成，已 ...